{
    "Trade/Device Name(s)": [
        "MTM301 Blood Glucose and Ketone Monitoring System"
    ],
    "Submitter Information": "Apex Biotechnology Corp.",
    "510(k) Number": "K202534",
    "Predicate Device Reference 510(k) Number(s)": [
        "K091547"
    ],
    "Regulatory Class": "Class II, Class I",
    "Product Code(s)": [
        "NBW",
        "JIN"
    ],
    "Summary Letter Date": "April 6, 2022",
    "Summary Letter Received Date": "January 6, 2022",
    "Submission Date": "December 30, 2021",
    "Regulation Number(s)": [
        "21 CFR 862.1345",
        "21 CFR 862.1435"
    ],
    "Regulation Name(s)": [
        "Glucose Test System",
        "Ketones (nonquantitative) Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose",
        "\u03b2-Ketone (B-Hydroxybutyrate)"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        "MTM301 Blood Glucose and Ketone Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor technology"
    ],
    "Methodologies": [
        "Enzyme-based biosensing (Glucose Oxidase for glucose, \u03b2-hydroxybutyrate dehydrogenase for ketone)"
    ],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strips",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for MTM301 Blood Glucose and Ketone Monitoring System for quantitative measurement of blood glucose and ketone using electrochemical biosensor technology",
    "Indications for Use Summary": "Intended for self-testing to quantitatively measure blood glucose or blood ketone in fresh capillary whole blood from the fingertip by people with diabetes mellitus at home as an aid in monitoring diabetes control; not for diagnosis, screening, or neonatal use",
    "fda_folder": "Clinical Chemistry"
}